Schedule 13D ownership disclosure

Sionna Therapeutics Inc

Common Stock, $0.001 par value per share · CUSIP: 829401108

Event date: 2025-02-10

Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.

Filing-level shares
Unavailable
Percent of class
Unavailable
  • RA Capital Management, L.P.Reported CIK 0001346824

    Shares: 10,445,322.00 · Class: 23.7%

  • Peter KolchinskyReported CIK 0001384859

    Shares: 10,445,322.00 · Class: 23.7%

  • Rajeev ShahReported CIK 0001619841

    Shares: 10,445,322.00 · Class: 23.7%

  • RA Capital Healthcare Fund, L.P.Reported CIK 0001315082

    Shares: 6,923,365.00 · Class: 15.7%

  • RA Capital Nexus Fund III, L.P.Reported CIK 0001883840

    Shares: 2,324,498.00 · Class: 5.3%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001415889-25-004419
Form type
SCHEDULE 13D
Filer
RA CAPITAL MANAGEMENT, L.P.
CIK
CIK 1346824
Filed
Feb 18, 2025
Reporting period
Feb 10, 2025
Description
Schedule 13D beneficial ownership

Explore SEC Filings Hub